← Open Payments lookup

KAREN MECKLER: Open Payments

NPI 1396800959 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$722 in 33 payments from 12 companies in 2025. Trend: 2023 $476 · 2024 $566 · 2025 $722

Food & beverage: $722
CompanyPaymentsAmount
ABBVIE INC.10$187
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$125
Otsuka America Pharmaceutical, Inc.4$112
E.R. Squibb & Sons, L.L.C.4$93
Neurocrine BioSciences, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$37
Almatica Pharma LLC1$25
Janssen Pharmaceuticals, Inc1$23
Axsome Therapeutics, Inc.1$22
Lundbeck LLC1$19

Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, INGREZZA, TRINTELLIX, LOREEV XR, SPRAVATO.

Industry payments across MD — which companies pay providers there.